New Paradigm For Medicinal Chemistry Offered By International Public-Private Partnership

The Wellcome Trust has announced a £4.1 million investment in a new initiative to generate small molecule inhibitors - “chemical probes” - for 25 proteins involved in epigenetic signalling, and to release these probes into the public domain with no restriction on use. Early stage information sharing on chemical probes is highly unusual and breaks with the tradition of keeping such data confidential.

More: continued here

Filed under: Pharma Industry on January 4th, 2009